• Skip to primary navigation
  • Skip to main content
IMMUNOLOGY2023™

IMMUNOLOGY2023™

May 11–15, 2023 | Washington, DC

  • Policy
    • COVID Policy
    • Press Credentials and Policy
  • Program
    • At a Glance
    • By Day
      • Thursday, May 11
      • Friday, May 12
      • Saturday, May 13
      • Sunday, May 14
      • Monday, May 15
    • President’s Program
    • Distinguished Lectures
    • Special Session
    • Major Symposia
    • Committee-Sponsored Sessions
    • Guest Sessions
    • Block Symposia
    • Poster Sessions
    • Award Presentations & Lectures
    • Career Development Opportunities
    • Exhibitor Workshops
    • Social Events
    • Meeting Guide (PDF)
  • For Speakers
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
    • Program Acknowledgements
    • Speaker Disclosures
  • Abstracts
    • View Abstracts Here
    • Poster Presentation Guidelines
    • Podium Presentation Guidelines
    • Submission Guidelines
    • Topic Categories
    • Editing or Withdrawing
    • Publication and Citation
    • Notification of Programming
  • Register
  • Awards
  • Careers
    • Jobs Board
    • For Employers
    • For Job Seekers
  • Hotels
  • Exhibitors
    • Exhibitor Workshops
    • Exhibitors – Start Here
    • Sponsorship
  • Sponsors
  • FAQ
  • Show Search
Hide Search
 Thursday, May 11, 2023     2:00 PM – 4:00 PM ET     Room 204ABC

Block Symposium

Vaccination and Vaccine-induced Responses against Pathogens at Target Sites

Chairs

  • Mangala Rao, Walter Reed Army Inst. of Res.
  • Todd Bradley, Univ. of Kansas Med. Ctr.

Speakers

  • Dennis Lapuente, Univ. Hosp. Erlangen, Germany, Adenoviral vector vaccines are effective mucosal booster modalities to elevate systemic and establish mucosal immunity against SARS-CoV-2
  • Qin Xu, NIAID, NIH, mRNA vaccination induces persistent pharyngeal mucosal B cell responses to SARS-CoV-2 in children
  • Wenxia Jiang, Indiana Univ. Sch. of Med., Boosting location of COVID-19 mRNA vaccine regulates the germinal center reaction
  • Devdoot Majumdar, Univ. of Vermont, Understanding mechanisms of adjuvancy in muscle by mRNA/lipid nanoparticles
  • Eric S. Geanes, Children's Mercy Kansas City, Blocking respiratory syncytial virus infection utilizing decoy ICAM-1 receptor proteins
  • Chunhong Dong, Georgia State Univ., Particulate characteristics of engineered nanoparticle vaccines modulate vaccine immunogenicity in an intranasal route
  • Allison N. Bucsan, NIAID, NIH, Visualizing the early immune response to Mycobacterium tuberculosis infection in macaques immunized with intravenous BCG

All IMMUNOLOGY2023™ attendees are required to comply with the AAI COVID-19 policy.

IMMUNOLOGY2023™
May 11—15, 2023
Walter E. Washington Convention Center
Washington, DC

AAI Courses
JOIN AAI NOW
Publish in The Journal of Immunology
Publish in ImmunoHorizons
Facebook
Twitter
Instagram
TikTok
LinkedIn

IMMUNOLOGY2023™

Copyright © 2025 The American Association of Immunologists, Inc. All rights reserved.

  • FAQ
  • Code of Conduct
  • COVID Policy
  • Press Policy
  • Privacy Policy

Jobs Board submissions for IMMMUNOLOGY2023™ are closed. Please post your jobs on the physical jobs board onsite in the convention center.